207 related articles for article (PubMed ID: 6998710)
21. Role of prostaglandins in the renal response to angiotensin-converting enzyme inhibition and renal artery occlusion.
van Leeuwen BH; Anderson WP; Johnston CI
J Cardiovasc Pharmacol; 1983; 5(5):883-8. PubMed ID: 6195481
[TBL] [Abstract][Full Text] [Related]
22. Mechanism of the protective effect of angiotensin-converting enzyme inhibition in hemorrhagic shock.
Trachte GJ; Lefer AM
Proc Soc Exp Biol Med; 1979 Oct; 162(1):54-7. PubMed ID: 228313
[No Abstract] [Full Text] [Related]
23. Antihypertensive action of a novel orally active angiotensin converting enzyme inhibitor altiopril calcium (MC-838) in several hypertensive models of rats: comparison with captopril.
Aono J; Koga T; Yamazaki T; Shiraki Y; Sakai K
Arch Int Pharmacodyn Ther; 1988; 292():203-22. PubMed ID: 3293542
[TBL] [Abstract][Full Text] [Related]
24. Angiotensin-induced release of prostacyclin from perfused organs.
Grodzińska L; Gryglewski RJ
Pharmacol Res Commun; 1980 Apr; 12(4):339-47. PubMed ID: 6994129
[No Abstract] [Full Text] [Related]
25. Potentiation of depressor responses to arachidonic acid by angiotensin converting enzyme inhibitors in the rat.
Hui SC; Dai S; Ogle CW
Clin Exp Pharmacol Physiol; 1984; 11(6):621-5. PubMed ID: 6100239
[TBL] [Abstract][Full Text] [Related]
26. Renal hemodynamic effects of captopril in anesthetized sodium-restricted dogs. Relative contributions of prostaglandin stimulation and suppressed angiotensin activity.
Carmines PK; Rosivall L; Till MF; Navar LG
Ren Physiol; 1983; 6(6):281-7. PubMed ID: 6359304
[TBL] [Abstract][Full Text] [Related]
27. Angiotensin-induced release of a prostacyclin-like substance from the lungs.
Dusting GJ
J Cardiovasc Pharmacol; 1981; 3(1):197-206. PubMed ID: 6160349
[TBL] [Abstract][Full Text] [Related]
28. Mechanism of captopril-induced renal vasodilatation in anesthetized dogs after nonhypotensive hemorrhage.
Wong PC; Zimmerman BG
J Pharmacol Exp Ther; 1980 Oct; 215(1):104-9. PubMed ID: 7005423
[TBL] [Abstract][Full Text] [Related]
29. The effects of captopril (SQ 14,225) on bradykinin-induced bronchoconstriction in the anesthetized guinea pig.
Greenberg R; Osman GH; O'Keefe EH; Antonaccio MJ
Eur J Pharmacol; 1979 Aug; 57(4):287-94. PubMed ID: 385332
[TBL] [Abstract][Full Text] [Related]
30. Effect of captopril on the bradykinin-induced release of prostacyclin from guinea-pig lungs and bovine aortic endothelial cells.
de Nucci G; Warner T; Vane JR
Br J Pharmacol; 1988 Nov; 95(3):783-8. PubMed ID: 2850062
[TBL] [Abstract][Full Text] [Related]
31. Inhibition by nicotine of the vasodilator effect of bradykinin: evidence for a prostacyclin-dependent mechanism.
Türker RK; Ercan ZS; Ersoy A; Zengil H
Arch Int Pharmacodyn Ther; 1982 May; 257(1):94-103. PubMed ID: 7052005
[TBL] [Abstract][Full Text] [Related]
32. Pharmacological evaluation in conscious dogs of factors involved in the renal vasodilator effect of captopril.
Wong PC; Zimmerman BG; Kraft E; Kounenis G; Friedman P
J Pharmacol Exp Ther; 1981 Dec; 219(3):646-50. PubMed ID: 7028950
[TBL] [Abstract][Full Text] [Related]
33. Role of extrarenal and intrarenal converting enzyme inhibition in renal vasodilator response to intravenous captopril.
Wong PC; Zimmerman BG
Life Sci; 1980 Oct; 27(14):1291-7. PubMed ID: 6255273
[No Abstract] [Full Text] [Related]
34. The hypotensive action of captopril and enalapril is not prostacyclin dependent.
Gerber JG; Franca G; Byyny RL; LoVerde M; Nies AS
Clin Pharmacol Ther; 1993 Nov; 54(5):523-32. PubMed ID: 8222495
[TBL] [Abstract][Full Text] [Related]
35. No role for prostaglandins and bradykinin in the autoregulation of renal blood flow.
Ogawa N; Ono H
Jpn J Pharmacol; 1985 Nov; 39(3):349-55. PubMed ID: 3937925
[TBL] [Abstract][Full Text] [Related]
36. Cutaneous blood flow changes and weal induced by intradermal bradykinin following pretreatment with indomethacin and captopril.
Wa TC; Cooke ED; Turner P
Eur J Clin Pharmacol; 1993; 44(1):41-5. PubMed ID: 8436153
[TBL] [Abstract][Full Text] [Related]
37. Increase in prostaglandins during converting enzyme inhibition.
Swartz SL; Williams GH; Hollenberg NK; Crantz FR; Levine L; Moore TJ; Dluhy RG
Clin Sci (Lond); 1980 Dec; 59 Suppl 6():133s-135s. PubMed ID: 6256109
[TBL] [Abstract][Full Text] [Related]
38. The converting enzyme inhibitor captopril stimulates prostacyclin synthesis by isolated rat aorta.
Düsing R; Scherhag R; Landsberg G; Glänzer K; Kramer HJ
Eur J Pharmacol; 1983 Aug; 91(4):501-4. PubMed ID: 6352286
[TBL] [Abstract][Full Text] [Related]
39. Vasodepressor property of the converting enzyme inhibitor captopril (SQ 14 225): the role of factors other than renin-angiotensin blockade in the rat.
Marks ES; Bing RF; Thurston H; Swales JD
Clin Sci (Lond); 1980 Jan; 58(1):1-6. PubMed ID: 6986224
[TBL] [Abstract][Full Text] [Related]
40. Potentiation of the renal responses to bradykinin by inhibition of neutral endopeptidase 3.4.24.11 and angiotensin-converting enzyme in anesthetized dogs.
Seymour AA; Sheldon JH; Smith PL; Asaad M; Rogers WL
J Pharmacol Exp Ther; 1994 Apr; 269(1):263-70. PubMed ID: 8169834
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
